Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma
Clinical trial NCT03409848 · COMPLETED
Trial details
- NCT number
- NCT03409848
- Sponsor
- AIO-Studien-gGmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2022-03-05
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.